Mr. Thomas has more than 40 years of experience in a variety of financial and accounting positions, with the last 33 years spent in the medical, pharmaceutical, and device fields. From 2001 until 2018, Mr. Thomas served as chief financial officer and secretary of CorMatrix Cardiovascular, a privately held medical device company and a director from 2001 until 2016. Since 1991, Mr. Thomas has served as chief financial officer, secretary, and director of Motion Reality, Inc., a privately held motion capture and simulation company. Since 2014, Mr. Thomas has served as a director of NantKwest, Inc., a public biotechnology company. From 2012 to 2019, Mr. Thomas served as a director of Novelion Therapeutics, Inc., formerly QLT, Inc., a public biotechnology company, and Medovex, Inc., a public medical device company. During the past 10 years, Mr. Thomas served as acting chief financial officer for DemeRx, Inc., MRI Interventions, Inc., MiMedx Group, Inc., and DARA BioSciences, and as a director of MRI Interventions, Inc. In 2018, Mr. Thomas was asked to return as the chief financial officer for DemeRx to assist them through a reorganization, which he did and continues to serve in that role. From 1999 and 2012, Mr. Thomas also served as a trustee and subsequently the chairman of the finance committee of The Walker School, a private Pre-K through grade 12 school. Mr. Thomas is a certified public accountant and graduated from the University of Virginia, McIntire School of Commerce.